ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today ...
Updated data showed the biotech's approach to the rare lung and liver condition helped restore functional protective proteins in a small study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results